TCTMD
@tctmd.bsky.social
930 followers 110 following 990 posts
Your source for breaking news, topical videos, and slides covering cardiovascular disease and interventions. Register at http://tctmd.com
Posts Media Videos Starter Packs
tctmd.bsky.social
Fewer than one-quarter of HFrEF patients are on guideline-directed medical therapy in the VA system. Hurdles to quadruple therapy include high drug costs, fragmented healthcare, transient contraindications, and limited clinician knowledge. www.tctmd.com/news/too-few...
Too Few HF Patients on Guideline-Directed Medical Therapy in VA System
Costs aren’t the only barrier to achieving optimal medication adherence, the data indicate.
www.tctmd.com
Reposted by TCTMD
crfheart.bsky.social
🌍 Experience the energy of #TCT2025 from anywhere — for FREE!

The TCT World Connect Livestream brings you front-row access to select high-impact sessions led by world-renowned experts. Don’t miss this global gateway to groundbreaking science and bold ideas!

https://ow.ly/ig9N50Xa5R8

#CardioSky
tctmd.bsky.social
Novel GDF-15, a biomarker of oxidative stress and inflammation, may help predict adverse outcomes for patients with suspected ACS, according to new data. Findings indicate that cytokine may aid in the decision to send patients home from the ED or admit them. www.tctmd.com/news/novel-b...
Novel Biomarker GDF-15 Helps Risk-Stratify Patients With Suspected ACS
As a complement to other biomarkers, the cytokine may aid in the decision to send patients home from the ED or admit them.
www.tctmd.com
Reposted by TCTMD
crfheart.bsky.social
✨ AI is changing everything, and healthcare is no exception. Join us for a visionary #TCT2025 keynote address as Dr. Robert Wachter shares bold insights from his new book “A Giant Leap.” Discover what AI means for the future of medicine & how you can navigate this new era! https://ow.ly/BCge50X9Yi5
tctmd.bsky.social
The PCSK9 inhibitor evolocumab reduces the risk of MACE better than standard therapy alone in people with no previous history of CV events, based on data from the VESALIUS-CV trial. Read more here: www.tctmd.com/news/evolocu...
Evolocumab Wins for Primary Prevention in VESALIUS-CV
The 12,000-patient trial of the PCSK9 inhibitor met its primary endpoints in high-risk individuals with no prior CV events.
www.tctmd.com
tctmd.bsky.social
Juan Granada discusses potential pharmacologic therapies that may impact the progression of aortic stenosis with Marc Dweck in the latest episode of Heart Valve Matters. www.tctmd.com/audio/medica...
Reposted by TCTMD
crfheart.bsky.social
💡 Want a front-row seat to cutting-edge research? Join Dr. Timothy Henry on 10/28 when he reveals findings from a multicenter registry examining AI-enabled ECG interpretation in STEMI.

🔍 Don’t miss the full lineup of late-breaking trials & science! www.tctconference.com/late-breakin...

#CardioSky
Reposted by TCTMD
crfheart.bsky.social
#Innovation that matters. #TCT2025 brings together the science, strategy, and global collaboration to transform heart care.

Don’t miss your chance to be part of it all! www.tctconference.com/register

#CardioSky
tctmd.bsky.social
Nearly all patients who develop CVD have at least one traditional risk factor, according to a new analysis. Risks include MI, heart failure, coronary heart disease, stroke, and higher cholesterol. More here: www.tctmd.com/news/risk-fa...
Risk Factors Present in Nearly All Patients Who Develop CVD
Keeping these factors in check and adhering to the AHA’s Life’s Essential 8, is the best way to prevent CVD, say researchers.
www.tctmd.com
Reposted by TCTMD
yaelmaxwell.bsky.social
Looking forward to being at #EACTS2025. Full coverage to come on @tctmd.bsky.social
tctmd.bsky.social
In this episode of Rox Heart Radio, Roxana Mehran sits down with TCT award winners Kenneth Rosenfield and Stephan Windecker. Listen now: www.tctmd.com/audio/meet-t...
tctmd.bsky.social
A new scientific statement from @americanheart.bsky.social encourages cardiologists and other healthcare practitioners to emphasize the importance of psychological health and well-being for patients during post-MI recovery. More here: www.tctmd.com/news/recogni...
Recognize and Enable Care for Post-MI Psychological Distress: AHA
It can be a sensitive topic for patients that should be broached gently, without confrontation or judgment, the committee notes.
www.tctmd.com
tctmd.bsky.social
From new @escardio.bsky.social valve guidelines to headlines from this year's #ESC2025 Congress, read all the top news stories to come out of TCTMD in September. www.tctmd.com/news/tctmds-...